Healthcare Guide

Comprehensive Metabolic Panel (CMP) Testing Market Worth 18,380 Mn $ by 2026

Lehdistötiedote   •   Joulu 03, 2019 10:29 EET

According to ARC, the global comprehensive metabolic panel (CMP) testing market size is expected to be worth around Us$ 18,380 million By 2026, jumping 7 percent during 2019 – 2026.

Acumen Research and Consulting’s study on the Comprehensive Metabolic Panel (CMP) Testing Market, offers in-depth information on the growth drivers and restraints impacting the growth of the market. It studies the potential market trajectory between 2019 and 2026. This market analysis report is compiled to help company’s access relevant information.

It reveals hidden growth opportunities for the market players. In addition to this, the report cautions them against possible threat. It therefore covers unparalleled information on the Comprehensive Metabolic Panel (CMP) Testing Market derived from trusted industrial sources. The findings included in the report are backed with relevant graphs and statistics. In addition to this, the report includes expert opinions and statistics from leading international organizations. It uses industry-leading analytical tools to offer accurate predictions on the market, which is the most sought-after by key players as they look to establish a strong foothold in the near future.

Download Free Sample Report Pages for Better Understanding@ https://www.acumenresearchandconsulting.com/request-sample/1587

The report uses quantitative and qualitative analysis on the information obtained. Based on results obtained, it offers refined growth forecasts for the global Comprehensive Metabolic Panel (CMP) Testing Market. According to the study, the market will witness growth at an accelerated pace in response to the rising demand for novel therapeutics. As a result of increasing prevalence of various illnesses worldwide, governments across the globe are tiring hard and launching several new initiatives to make human resources healthier and fitter than ever. Several countries have ensured access to favourable reimbursement policies, which according to the report, is a chief driver of this market.

In addition to the aforementioned factors, increasing investment towards research and development activities in the pharmaceutical sector is expected to encourage growth in the global market.

Scope of the Report:

The report first uses historic data from different companies. The data collected is used to analyses the growth of industries in the past years. It includes data from the year 2015 to the year 2019. The forecast data provides the reader with an understating of the future of the market. The same data is used to predict the expectation of the companies and how they are expected to evolve in the coming years. The research provides historical as well as estimated data from the year 2019 to 2026. The details in the report give a brief overview of the market by examining its historical data, the current data, and forecast data to understand the growth of the market.

Competitive Landscape

It covers in-depth information on the competitive rivalry witnessed among the leading market players. The report calculates the investment feasibility of this market, which is an indispensable information for potential new entrants. Furthermore, it highlights the most attractive pockets within the global market to help companies plan their investments accordingly. Therefore, for the purpose of the analysis, the report conducts a Porter’s five forces analysis. Through this, it studies the bargaining power suppliers and buyers. The threat to companies from substitutes and new entrants is evaluated as well.

The report dedicates an entire section to discuss the competitive landscape of the market in detail. It studies the growth trajectory of a certain company based on price trend analysis, recent developments, and various other factors.

List of Companies

The report is intended to offer an executive-level blueprint of this market. Therefore, it profiles some of the leading companies operating in the market. Some of the key players in the global Comprehensive Metabolic Panel (CMP) Testing Market include Sonic Healthcare, Quest Diagnostics, UNIPATH, Laboratory Corporation of America Holdings (LabCorp), Abbott, SYNLAB International GmbH and among others. Over the past few years, the companies have increased their production capacity to meet the growing demand. Companies are expected to focus on new product launches and on consolidating their presence in the coming years.

It conducts SWOT Analysis on the companies to gain insights into the strengths and weaknesses of the companies profiled. The analysis also highlighted the most lucrative opportunities for the companies and challenges that could pose threat in the coming years.

The report evaluated the companies and their market positions in terms of growth strategies they adopted over the years and the impact of the same on the overall Comprehensive Metabolic Panel (CMP) Testing Market. Furthermore, the report profiled these companies on the basis of the corporate policies, business collaborations, mergers and acquisitions, product portfolio, and recent launches.

Market Segment Analysis:

Acumen Research report focuses on market attractiveness by assessing the key market segments. The report also combines region-wise segments for a better understanding of the supply and demand ratio of the this market. This exclusive study of the report analyzes the present and future market scenario and the industry trends that are influencing the growth of the segments. Besides, the report also covers the value chain analysis, supply chain analysis, and year-on-year basis analysis of the this market.

Market Segmentation

Market By Disease

  • Kidney Disease
  • Liver Disease
  • Diabetes
  • Others

Market By Test Type

  • Proteins
  • Electrolytes
  • Kidney Tests
  • Liver Functional Tests
  • Glucose

Market By End-Use

  • Laboratories
  • PoC

Market Regional Analysis:

Based on the regions, the global Comprehensive Metabolic Panel (CMP) Testing Market is segmented into -North America (US and Canada), Europe (UK, Germany, France, Spain and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea and Rest of Asia-Pacific), Latin America (Mexico, Brazil and Rest of Latin America), Middle East & Africa (GCC, South Africa and Rest of MEA)

Key Questions Answered in the Report

The report addresses key questions concerning the market evolution and overarching trends shaping global market growth. Some of the key questions answered in the report include-

  • What is the overall structure of the market?
  • What was the historical value and what is the forecasted value of the market?
  • What are the key product level trends in the market?
  • What are the market level trends in the market?
  • Which of the market players are leading and what are their key differential strategies to retain their stronghold?
  • Which are the most lucrative regions in the market space?

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Comprehensive Metabolic Panel (CMP) Testing
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Comprehensive Metabolic Panel (CMP) Testing Market By Disease
1.2.2.1. Global Comprehensive Metabolic Panel (CMP) Testing Market Revenue and Growth Rate Comparison By Disease (2015-2026)
1.2.2.2. Global Comprehensive Metabolic Panel (CMP) Testing Market Revenue Share By Disease in 2018
1.2.2.3. Kidney Disease
1.2.2.4. Liver Disease
1.2.2.5. Diabetes
1.2.2.6. Others
1.2.3. Comprehensive Metabolic Panel (CMP) Testing Market By Test Type
1.2.3.1. Global Comprehensive Metabolic Panel (CMP) Testing Market Revenue and Growth Rate Comparison By Test Type (2015-2026)
1.2.3.2. Proteins
1.2.3.3. Electrolytes
1.2.3.4. Kidney Tests
1.2.3.5. Liver Functional Tests
1.2.3.6. Glucose
1.2.4. Comprehensive Metabolic Panel (CMP) Testing Market By End-Use
1.2.4.1. Global Comprehensive Metabolic Panel (CMP) Testing Market Revenue and Growth Rate Comparison By End-Use (2015-2026)
1.2.4.2. Laboratories
1.2.4.3. PoC
1.2.5. Comprehensive Metabolic Panel (CMP) Testing Market By Geography
1.2.5.1. Global Comprehensive Metabolic Panel (CMP) Testing Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.5.2. North America Comprehensive Metabolic Panel (CMP) Testing Market Revenue and Growth Rate (2015-2026)
1.2.5.3. Europe Comprehensive Metabolic Panel (CMP) Testing Market Revenue and Growth Rate (2015-2026)
1.2.5.4. Asia-Pacific Comprehensive Metabolic Panel (CMP) Testing Market Revenue and Growth Rate (2015-2026)
1.2.5.5. Latin America Comprehensive Metabolic Panel (CMP) Testing Market Revenue and Growth Rate (2015-2026)
1.2.5.6. Middle East and Africa (MEA) Comprehensive Metabolic Panel (CMP) Testing Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2018
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Comprehensive Metabolic Panel (CMP) Testing Major Manufacturers in 2018
3.2. Manufacturing Plants Distribution of Global Comprehensive Metabolic Panel (CMP) Testing Major Manufacturers in 2018
3.3. R&D Status and Technology Source of Global Comprehensive Metabolic Panel (CMP) Testing Major Manufacturers in 2018
3.4. Raw Materials Sources Analysis of Global Comprehensive Metabolic Panel (CMP) Testing Major Manufacturers in 2018

CHAPTER 4. COMPREHENSIVE METABOLIC PANEL (CMP) TESTING MARKET BY DISEASE

4.1. Global Comprehensive Metabolic Panel (CMP) Testing Revenue By Disease
4.2. Kidney Disease
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Liver Disease
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Diabetes
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Others
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. COMPREHENSIVE METABOLIC PANEL (CMP) TESTING MARKET BY TEST TYPE

5.1. Global Comprehensive Metabolic Panel (CMP) Testing Revenue By Test Type
5.2. Proteins
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Electrolytes
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Kidney Tests
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.5. Liver Functional Tests
5.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.6. Glucose
5.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. COMPREHENSIVE METABOLIC PANEL (CMP) TESTING MARKET BY END-USE
6.1. Global Comprehensive Metabolic Panel (CMP) Testing Revenue By End-Use
6.2. Laboratories
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. PoC
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. NORTH AMERICA COMPREHENSIVE METABOLIC PANEL (CMP) TESTING MARKET BY COUNTRY
7.1. North America Comprehensive Metabolic Panel (CMP) Testing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. North America Comprehensive Metabolic Panel (CMP) Testing Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
7.3.1. U.S. Comprehensive Metabolic Panel (CMP) Testing Market Revenue and Forecast By Disease, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
7.3.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Disease, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
7.4.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)

CHAPTER 8. EUROPE COMPREHENSIVE METABOLIC PANEL (CMP) TESTING MARKET BY COUNTRY
8.1. Europe Comprehensive Metabolic Panel (CMP) Testing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Europe Comprehensive Metabolic Panel (CMP) Testing Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Disease, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
8.3.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Disease, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
8.4.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Disease, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
8.5.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Disease, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
8.6.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Disease, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
8.7.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)

CHAPTER 9. ASIA-PACIFIC COMPREHENSIVE METABOLIC PANEL (CMP) TESTING MARKET BY COUNTRY
9.1. Asia-Pacific Comprehensive Metabolic Panel (CMP) Testing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Asia-Pacific Comprehensive Metabolic Panel (CMP) Testing Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Disease, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
9.3.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Disease, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
9.4.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Disease, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
9.5.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Disease, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
9.6.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Disease, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
9.7.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Disease, 2015 - 2026 ($Million)
9.8.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
9.8.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)

CHAPTER 10. LATIN AMERICA COMPREHENSIVE METABOLIC PANEL (CMP) TESTING MARKET BY COUNTRY
10.1. Latin America Comprehensive Metabolic Panel (CMP) Testing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Latin America Comprehensive Metabolic Panel (CMP) Testing Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Disease, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
10.3.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
10.4. Mexico
10.4.1. Market Revenue and Forecast By Disease, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
10.4.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Disease, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
10.5.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)

CHAPTER 11. MIDDLE EAST & AFRICA COMPREHENSIVE METABOLIC PANEL (CMP) TESTING MARKET BY COUNTRY
11.1. Middle East & Africa Comprehensive Metabolic Panel (CMP) Testing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Middle East & Africa Comprehensive Metabolic Panel (CMP) Testing Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. GCC
11.3.1. Market Revenue and Forecast By Disease, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
11.3.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
11.4. South Africa
11.4.1. Market Revenue and Forecast By Disease, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
11.4.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
11.5. Rest of Middle East & AFRICA
11.5.1. Market Revenue and Forecast By Disease, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
11.5.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)

CHAPTER 12. COMPANY PROFILE
12.1. Sonic Healthcare
12.1.1. Company Snapshot
12.1.2. Overview
12.1.3. Financial Overview
12.1.4. Type Portfolio
12.1.5. Key Developments
12.1.6. Strategies
12.2. Quest Diagnostics
12.2.1. Company Snapshot
12.2.2. Overview
12.2.3. Financial Overview
12.2.4. Type Portfolio
12.2.5. Key Developments
12.2.6. Strategies
12.3. UNIPATH
12.3.1. Company Snapshot
12.3.2. Overview
12.3.3. Financial Overview
12.3.4. Type Portfolio
12.3.5. Key Developments
12.3.6. Strategies
12.4. Laboratory Corporation of America Holdings (LabCorp)
12.4.1. Company Snapshot
12.4.2. Overview
12.4.3. Financial Overview
12.4.4. Type Portfolio
12.4.5. Key Developments
12.4.6. Strategies
12.5. Abbott
12.5.1. Company Snapshot
12.5.2. Overview
12.5.3. Financial Overview
12.5.4. Type Portfolio
12.5.5. Key Developments
12.5.6. Strategies
12.6. SYNLAB International GmbH
12.6.1. Company Snapshot
12.6.2. Overview
12.6.3. Financial Overview
12.6.4. Type Portfolio
12.6.5. Key Developments
12.6.6. Strategies
12.7. Others
12.7.1. Company Snapshot
12.7.2. Overview
12.7.3. Financial Overview
12.7.4. Type Portfolio
12.7.5. Key Developments
12.7.6. Strategies

CHAPTER 13. RESEARCH APPROACH
13.1. Research Methodology
13.1.1. Initial Data Search
13.1.2. Secondary Research
13.1.3. Primary Research
13.2. Assumptions and Scope

The report is readily available and can be dispatched immediately after payment confirmation.

To Purchase this Premium Report@ https://www.acumenresearchandconsulting.com/buy-now/0/1587

Contact Us:

Acumen Research and Consulting

Email: sales@acumenresearchandconsulting.com

Phone: +1 407 915 4157

Healthcare Guide provides latest trends, news, research studies and articles on healthcare industry.